Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Innate Pharma
  6. Consensus
    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
Real-time Euronext Paris  -  05/20 11:35:15 am EDT
2.906 EUR   -1.69%
05/20INNATE PHARMA : Outcome of Innate Pharma's 2022 Annual General Meeting - Form 6-K
PU
05/20Innate Pharma S.A. Announces Supervisory Board Changes
CI
05/10TRANSCRIPT : Innate Pharma S.A., Q1 2022 Earnings Call, May 10, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on INNATE PHARMA
Target Price consensus revisions : last 18 months
Recommendations (Chart) INNATE PHARMA
Analyst Recommendations on INNATE PHARMA
2021ANALYST RECOMMENDATIONS : BHP, Lear, Naked Wines, Teradata, Visteon...
2021INNATE PHARMA S A : SVB Leerink Upgrades Innate Pharma to Outperform from Market Perform
MT
2020INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From Outperform, Adjusts Price Targ..
MT
2020INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50 From $13, Keeps at Buy
MT
2020INNATE PHARMA S A : Goldman Sachs Starts Innate Pharma at Neutral With $4.75 Price Target
MT
2015France's 'economic patriotism' is not what it seems
RE
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 2,91 €
Average target price 8,12 €
Spread / Average Target 179%
High Price Target 12,00 €
Spread / Highest target 313%
Low Price Target 4,00 €
Spread / Lowest Target 37,6%
Consensus detail
Consensus revision (last 18 months)